Novonix Limited (NVX) AI Stock Analysis

Novonix Limited specializes in the development and provision of advanced battery materials, equipment, and services primarily catering to the North American lithium-ion battery market. The company operates across three segments: Graphite Exploration and Mining, Battery Technology, and Battery Materials. Graphite Exploration and Mining focuses on exploring and mining graphite resources in Australia for battery anode material production. Battery Technology develops battery cell testing equipment, manufactures batteries, and offers consulting services to improve battery safety and efficiency. Battery Materials conducts research, development, and manufacturing of high-performance battery anode materials used in consumer electronics and electric vehicles. Headquartered in Brisbane, Australia, the company was originally incorporated as Graphitecorp Limited.

Novonix generated a 5-year revenue CAGR of 1.5% from FY2020 to FY2025. Annual revenue moved from $6.1M in FY2021 to $3.7M in FY2022, reached $8.1M in FY2023, and then fell 27.3% to $5.9M in FY2024 and 4.0% to $5.6M in FY2025. Gross margin contracted from 69.8% in FY2024 to -433.3% in FY2025. The company posted an operating margin of -929.6% and a net loss of -$92.8M in FY2025. For the trailing twelve months ended June 30, 2026, revenue stood at $5.6M with an operating margin of -925.8% and EPS of -$5.72. In the quarter ended June 30, 2026, quarterly revenue fell 10.1% year-over-year.

As of June 30, 2026, Novonix held $63.7M in cash and short-term investments against total debt of $95.8M, resulting in net debt of $32.2M. Shareholders' equity was $152.8M with total assets of $265.0M. The company reported a current ratio of 0.97 and a debt-to-equity ratio of 0.63. During FY2025, operating cash flow was -$42.2M and capital expenditures were $60.2M, bringing free cash flow to -$102.4M. Its share count changed -76.4% over five years.

Novonix has a market capitalization of $53.6M and an enterprise value of $100.6M. The stock trades at a price-to-sales multiple of 9.5x and an EV-to-revenue multiple of 17.9x, compared to a median price-to-sales of 1.5x for its US-listed Industrials peers. Its price-to-book ratio stands at 0.4x. On October 16, 2026, shares closed at $2.15, down 78.7% year-to-date and 89.0% over the past year. Over the same 1-year period, the S&P 500 (SPY) returned 16.8%, and the index returned 83.0% over five years.

The mean analyst price target for Novonix is $5.00, compared to its last close of $2.15 on October 16, 2026, representing a target difference of 132.6%. For the fiscal year ending December 31, 2026, analysts estimate revenue of $4.7M and an EPS of -$2.70, which reflects an expected EPS growth of 51.8%. The revenue estimate for the next fiscal year is $0. Over the last four quarters, the company delivered 2 EPS beats.

This page is an AI-written research summary of Novonix Limited (NVX). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: NVX income statement, NVX balance sheet, NVX key metrics, NVX analyst forecast, NVX chart. See the NVX stock overview for the latest quote and news.